Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Remember you don't increase staff with slowing business. Also, keep in mind, GALP placed three orders including the last one of over $160K. Nobody places that size order (3rd) for a project that is ineffective. Have a feeling lots of stuff being worked on.
Tick Tock Tick Tock
Industrial Nanotech, Inc. Reports Significant Progress with India Sales Office 06/05 08:00 AM
NAPLES, Fla.--(BUSINESS WIRE)-- Industrial Nanotech, Inc. (INTK:$0.02,00$-0.003,0-13.04%) , an emerging global leader in nanotechnology based energy saving and sustainable solutions announced today that the Company’s plan to open a Corporate sales office in India is making significant positive progress. The company has already begun filling sales orders from new India manufacturing customers and has forged an alliance with an established equipment manufacturer in Bangalore who will act as a sales representative and applicator. The Company is also reviewing locations for warehousing and office space in Bangalore.
“Since we began our plans to open a sales office in India, we’ve made significant progress,” stated Francesca Crolley, VP of Business Development for Industrial Nanotech, Inc. (INTK:$0.02,00$-0.003,0-13.04%) “Our marketing efforts have already produced over $18,000.00 US in sales to industrial manufacturers in India even before our office has officially opened. The companies there are truly progressive when it comes to energy savings, and have made it clear they are looking for the solutions that our patented Nansulate® energy saving coatings provide. Additionally, after a meeting with a Bangalore based equipment manufacturer, we have forged a relationship where their company will not only promote the coating to their current clients, but also act as a sales representative and applicator for Nansulate® in Southern India. This gives us a distinct advantage to grow sales and lead generation prior to our office opening, and should further accelerate our market penetration in this important country.”
India's manufacturing sector kept up its steady expansion in May, with fast-rising output evened out by slowing growth of domestic order books. The HSBC manufacturing Purchasing Managers' Index (PMI), compiled by Markit, slipped marginally to 54.8 in May from 54.9 in April. It has stayed above the 50 mark, that separates growth from contraction, for a little over three years now. The PMI survey showed new export orders continued to grow at a strong pace in May, despite economic and political strife taking hold in Europe, one of India's main trading partners.
About Nansulate®
Nansulate® is the Company's patented product line of award winning, specialty coatings containing a nanotechnology based material and which are well-documented to provide the combined performance qualities of thermal insulation, corrosion prevention, resistance to mold growth, fire resistance, chemical resistance and lead encapsulation in an environmentally safe, water-based, coating formulation. The Nansulate® Product Line includes industrial, residential, agricultural and solar thermal insulation coatings. Additional information about the Company and its products can be found at their websites, (www.inanotk.com) and (www.nansulate.com). Blog: www.nansulate.com/nanoblog, Twitter: www.twitter.com/NanoPioneer, Facebook: www.facebook.com/Nansulate.
About Industrial Nanotech Inc. (INTK:$0.02,00$-0.003,0-13.04%)
Industrial Nanotech Inc. (INTK:$0.02,00$-0.003,0-13.04%) is a global nanoscience solutions and research leader and member of the U.S. Green Building Council. The Company develops and commercializes new and innovative applications for sustainable nanotechnology which are sold worldwide.
Safe Harbor Statement
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic and business conditions, and the ability to attract and retain skilled personnel. The Company is not obligated to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.
Source: Industrial Nanotech, Inc. (INTK:$0.02,00$-0.003,0-13.04%)
Amigo Mike, Bob, etc
Got the news at 6:16 AM on my Fidelity Active Trader platform.
Looking forward to contined good news on the conference call. Hanging tough!
PS Thank you Amigo Mike for all your informative postings.
Larry
Health Enhancement Products, Inc. sets June 15 date for investor conference call
Bloomfield Hills, MI – (Marketwire – 05/31/2012) Arizona-based algae producer Health Enhancement Products (OTC.BB: HEPI.OB – News) has set a June 15 date to conduct an investor/analyst conference call to provide updates on various research and company activities.
“Rather than further delay any announcements regarding the Company’s research and development initiatives, we’ve opted to set a date without all of the data in hand,” states Andrew Dahl, President and CEO. “We’ll share what we have and present our plan to move forward.”
Over past two years, Health Enhancement Products has been conducting a research and product development program to isolate and characterize bioactive compounds within its proprietary algal extract, which is derived from a complex culture of algae grown in purified water at the Company’s facility in Scottsdale, Arizona.
The Company had launched an in vivo study in mid-January to confirm previous results and test various isolates and refined fractions. Results were tentatively scheduled for late March. However, the Company opted to expand the scope and conduct more definitive genetic testing. Further, the Company requested that blood lipid profiles be re-run to assure accuracy.
“It was an opportunity to delve deeper into the method of regulation and quantitatively assess the efficacy of these isolates and fractions. We had samples in hand, a window of time to accomplish this work, and we took it,” says Dahl. “The enhanced genetic testing will shed new light on how the bioactive compounds work and whether the methods of isolation we’re using are actually giving us isolates that are still efficacious.”
Company principals also requested that a portion of DNA samples from the most recent in vivo study be studied by Smiti Gupta, PhD, assistant professor of Nutrition and Food Science at Wayne State University who validated the cholesterol bioactivity in the summer of 2009. Those real-time genetic test results were returned late Wednesday, May 23 indicating one of eight groups tested showed a two-fold increase in ApoA1 expression as compared to controls. However, the Company and Gupta caution that these are preliminary results. More details will be provided on the conference call.
In previous studies, the Company had made various attempts to isolate the bioactive compounds which resulted in some test samples that worked quite well while others seemed to falter.
“It isn’t enough to say that we’ve isolated a known bioactive,” explains Dahl. “Once we’re done isolating and analyzing, that isolate still needs to remain active and do its job.”
Dahl will also update participants on the Company’s progress in constructing a new clean room at its new Scottsdale facility and provide timing on the move-in. Company CFO Philip Rice will present interim financials, recent developments and a brief overview of the latest 10-Q filing.
The June 15 call will begin at 11:00AM EDT and conclude at 12:15PM EDT. The format is basic, consisting of 25 minutes of presentation followed by 20 minutes of Q&A. Callers will be encouraged to submit questions for the Q&A session that follows prepared remarks.
Participant Dial-In Numbers:
TOLL-FREE 1-877-941-2068
TOLL/INTERNATIONAL 1-480-629-9712
For replay at a later date:
TOLL-FREE 1-877-5176
TOLL/INTERNATIONAL 1-858-384-5517
Available from July 15 to July 29, 2012
Replay PIN Number: 4543729
Because of prior demand, the number of available call-in lines has been doubled.
About Health Enhancement Products, Inc.
Health Enhancement Products, Inc. (OTC.BB: HEPI.OB) is a health & wellness company engaged in the development of natural products derived from algae cultures for use as dietary supplements and food ingredients. These natural products are extracted from living algae grown in purified water.
Safe Harbor Statement
Except for any historical information, the matters discussed in this press release contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements involve risks and uncertainties. A number of factors could cause actual results to differ from those indicated in the forward-looking statements, including the timing of completion of a trial, actual future clinical trial results being different than the results the company has obtained to date, and the company's ability to secure funding. Such statements are subject to a number of assumptions, risks and uncertainties. Readers are cautioned that such statements are not guarantees of future performance and those actual results or developments may differ materially from those set forth in the forward-looking statements. The company undertakes no obligation to publicly update or revise forward-looking statements, whether as a result of new information or otherwise.
Contact:
Health Enhancement Products, Inc.
John Gorman, Executive Vice-President, Board Director
(888) 871 6903 extension 702
Industrial Nanotech, Inc. Announces Successful Installation of Initial Projects with Major U.S. Manufacturers 05/21 08:50 AM
NAPLES, Fla.--(BUSINESS WIRE)-- Industrial Nanotech, Inc. (INTK:$0.0285,$-0.0014,-4.68%) , an emerging global leader in nanotechnology based energy saving and sustainable solutions announced today that they have recently completed initial installations of the Company’s Nansulate® thermal insulation and protective coatings with several major U.S. manufacturers in the paper and textile industries for insulation, surface protection and personnel protection.
“Saving energy is now becoming a more immediate priority for U.S. manufacturers,” stated Francesca Crolley, V.P. Business Development for Industrial Nanotech, Inc. (INTK:$0.0285,$-0.0014,-4.68%) “While many of our previous larger projects have been overseas due to the culture of sustainability and regulatory mandates for energy savings, we are now seeing a significant increase in the focus on sustainability by U.S. companies and these initial projects are expected to expand into company wide initiatives in the very near future. Companies we have been working with in the U.S., including the most recent installations in textile facilities and a paper mill are now at a point where these types of energy saving projects are moving forward.”
Crolley continues, “For over eight years, Nansulate® has provided significant energy savings and protective benefits for a number of industries, including global textile manufacturer Coats plc, who projected saving more than 10% in energy costs and 2% in carbon emissions throughout their plants in addition to lowering the dye house internal temperatures for improved worker safety. Henateks, a textile manufacturer for major sports apparel companies, charted an average of 20% reduction of energy consumption and reduced their liquid natural gas consumption in the first two years by over 1 million cubic meters per year. Nansulate® coatings have also provided solutions at paper mills in countries such as India, and were a topic of a presentation at last year’s PaperTech Expo. Our coatings for building insulation are also just as popular for energy savings, reducing the internal temperature of a critical data center for Mexico’s Social Security and Health Administration (IMSS) by 27% to reduce heat related server shut down, and being implemented as a sustainable building solution in the Suvarnabhumi International Airport in Bangkok, Thailand.”
“Our experience is that energy saving projects are now more important than ever for US companies,” concluded Ms. Crolley, “and our patented coatings offer them the ability to implement a project at an affordable cost with short payback period, typically 6-18 months. We expect to see many more projects in the future with U.S. based manufacturers, in addition to being busier than ever with overseas projects as the world continues to seek innovative paths to sustainability.”
About Nansulate®
Nansulate® is the Company's patented product line of award winning, specialty coatings containing a nanotechnology based material and which are well-documented to provide the combined performance qualities of thermal insulation, corrosion prevention, resistance to mold growth, fire resistance, chemical resistance and lead encapsulation in an environmentally safe, water-based, coating formulation. The Nansulate® Product Line includes industrial, residential, agricultural and solar thermal insulation coatings. Additional information about the Company and its products can be found at their websites, (www.inanotk.com) and (www.nansulate.com). Blog: www.nansulate.com/nanoblog, Twitter: www.twitter.com/NanoPioneer, Facebook: www.facebook.com/Nansulate.
About Industrial Nanotech Inc. (INTK:$0.0285,$-0.0014,-4.68%)
Industrial Nanotech Inc. (INTK:$0.0285,$-0.0014,-4.68%) is a global nanoscience solutions and research leader and member of the U.S. Green Building Council. The Company develops and commercializes new and innovative applications for sustainable nanotechnology which are sold worldwide.
Safe Harbor Statement
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic and business conditions, and the ability to attract and retain skilled personnel. The Company is not obligated to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.
Source: Industrial Nanotech, Inc. (INTK:$0.0285,$-0.0014,-4.68%)
ndustrial Nanotech, Inc. Announces More Orders for Galp Energia Oil RefineryLast update: 5/18/2012 8:00:02 AM
NAPLES, Fla., May 18, 2012 (BUSINESS WIRE) -- Industrial Nanotech, Inc. (INTK), an emerging global leader in nanotechnology based energy saving and sustainable solutions announced today that they have received an order of 2,150 gallons of the Company's patented Nansulate(R) Translucent PT insulation and corrosion control coating from Montaco, the industrial contractor awarded the bid to apply Nansulate(R) on fuel oil tanks at the Matosinhos refinery in Portugal owned by Galp Energia. This total price of the order is $163,298 and is the third order in the past 19 months for projects at the refinery covering both fuel oil storage tanks and an oil pipeline for insulation and corrosion prevention.
"Galp Energia continues to upgrade their Portugal refineries on an ongoing basis and we look forward continuing to supply them with Nansulate(R) Translucent PT," stated Francesca Crolley, V.P. of Business Development for Industrial Nanotech, Inc. "The fuel oil storage tank project, which began with large applications of Nansulate(R) last year, was paused during the winter season and is continuing now that the warmer weather has returned. Nansulate(R) industrial coatings provide a superior solution for insulation of pipes, tanks and other equipment due to their excellent thermal performance as well as combination of other qualities such as corrosion prevention, moisture resistance, and ability to stand up to the harshest of environments."
Galp Energia SGPS SA, Portugal's biggest oil company, has activities that span from exploration and production of oil and natural gas to refining and marketing oil products, natural gas marketing and sales and power generation. Galp Energia processes crude oil in its refineries at Sines and Matosinhos. These refineries have currently a total refining capacity of 330,000 barrels of crude oil a day. Their activities are expanding strongly worldwide and are predominantly located in Portugal, Spain, Brazil, Angola, Venezuela, Mozambique, Cape Verde, Guinea-Bissau, Swaziland, Gambia, East Timor, Uruguay and Equatorial Guinea
About Nansulate(R)
Nansulate(R) is the Company's patented product line of award winning, specialty coatings containing a nanotechnology based material and which are well-documented to provide the combined performance qualities of thermal insulation, corrosion prevention, resistance to mold growth, fire resistance, chemical resistance and lead encapsulation in an environmentally safe, water-based, coating formulation. The Nansulate(R) Product Line includes industrial, residential, agricultural and solar thermal insulation coatings. Additional information about the Company and its products can be found at their websites, () and (). Blog: , Twitter: , Facebook: .
About Industrial Nanotech Inc.
Industrial Nanotech Inc. is a global nanoscience solutions and research leader and member of the U.S. Green Building Council. The Company develops and commercializes new and innovative applications for sustainable nanotechnology which are sold worldwide.
Safe Harbor Statement
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic and business conditions, and the ability to attract and retain skilled personnel. The Company is not obligated to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.
SOURCE: Industrial Nanotech, Inc.
Industrial Nanotech, Inc. Francesca Crolley, US & Canada: 800-767-3998 International: +1 239-254-0346 Email: investini@inanotk.com
Copyright Business Wire 2012
News provided by Dow Jones NewswiresSM, PR News Wire and Business Wire. Dow Jones Newswires is a service mark of Dow Jones & Company. PR News Wire is a Trademark of PR Newswire Association, Inc. Business Wire is a registered trademark and service mark of Business Wire.
TD Ameritrade is not responsible for the quality and suitability of third party financial or investment information or services. Brokerage services provided by TD Ameritrade, Inc., member FINRA/SIPC/NFA. TD Ameritrade is a trademark jointly owned by TD Ameritrade IP Company, Inc. and The Toronto-Dominion Bank. All rights reserved. Used with permission.
Industrial Nanotech, Inc. Announces Expansion to India with Corporate Sales Office 05/15 08:00 AM
NAPLES, Fla.--(BUSINESS WIRE)-- Industrial Nanotech, Inc. (INTK:$0.0342,$-0.0028,-7.57%) , an emerging global leader in nanotechnology based energy saving and sustainable solutions announced today that the Company is opening a Corporate Sales Office in India with the next 4-6 weeks. Industrial Nanotech, Inc. (INTK:$0.0342,$-0.0028,-7.57%) has seen significantly increased demand in India for their Nansulate® energy saving and protective coatings from OEM manufacturers as well as end manufacturing users to reduce energy costs. The company plans to establish an office first in Southern India, in or near Bangalore, with expansion to Northern India and Western India in the near future.
“India has become an increasingly important country as their manufacturing sectors and economy as a whole continue to have a healthy growth rate,” stated Francesca Crolley, VP of Business Development for Industrial Nanotech, Inc. (INTK:$0.0342,$-0.0028,-7.57%) “We began a strategy this year focused on boosting our marketing and brand presence in India as an energy saving solution and it has returned significant results. These include multiple inquiries from manufacturers that want to use Nansulate® coatings for insulation of their equipment for energy savings and surface temperature reduction, as well as a meeting with a leading OEM manufacturer of process cooling systems with 14 locations throughout India, and an international client base, that is interested in incorporating our technology into the process cooling systems they manufacture and sell. We have seen our marketing, which was focused on commercial and industrial, bring in sales and inquiries from multiple markets and at such a response level that it was obvious to us that setting up an Industrial Nanotech, Inc. (INTK:$0.0342,$-0.0028,-7.57%) office in India, staffed by a sales and technical support team which we hire and train, was the logical next step. The availability of a well educated workforce with an excellent work ethic presents a tremendous opportunity for the Company and will allow us to both accommodate factory visit requests from around the country with our own technical teams, as we do in the US, and the ability to more rapidly service and grow this vital market.”
India's economic growth is expected to remain robust in 2012 and 2013, despite likely headwind of double-dip recessions in Europe and the US, according to a United Nations' annual economic report - World Economic Situation and Prospects 2012. The Indian economy is expected to grow between 7.7 per cent and 7.9 per cent this year, as per the report. India is the second most preferred destination for foreign investors, according to the report 'Doing Business in India' by Ernst & Young. The report explores India's key sectors, investment climate, funding scenario, laws and regulations, to aid companies that are doing, or plan to do business in India.
About Nansulate®
Nansulate® is the Company's patented product line of award winning, specialty coatings containing a nanotechnology based material and which are well-documented to provide the combined performance qualities of thermal insulation, corrosion prevention, resistance to mold growth, fire resistance, chemical resistance and lead encapsulation in an environmentally safe, water-based, coating formulation. The Nansulate® Product Line includes industrial, residential, agricultural and solar thermal insulation coatings. Additional information about the Company and its products can be found at their websites, (www.inanotk.com) and (www.nansulate.com). Blog: www.nansulate.com/nanoblog, Twitter: www.twitter.com/NanoPioneer, Facebook: www.facebook.com/Nansulate.
About Industrial Nanotech Inc. (INTK:$0.0342,$-0.0028,-7.57%)
Industrial Nanotech Inc. (INTK:$0.0342,$-0.0028,-7.57%) is a global nanoscience solutions and research leader and member of the U.S. Green Building Council. The Company develops and commercializes new and innovative applications for sustainable nanotechnology which are sold worldwide.
Safe Harbor Statement
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic and business conditions, and the ability to attract and retain skilled personnel. The Company is not obligated to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.
Source: Industrial Nanotech, Inc. (INTK:$0.0342,$-0.0028,-7.57%)
Well said BigWave. If you are not happy how the company is run, may I suggest the "sell" button and this way you can move on to greener pastures.
We will get information when the company feels that they are protected and have something to give us.
In the meantime, the stock is holding up like a champ compared to hundreds of other microcaps that I follow, There is a "very quiet" buyer on the bid.
Reprint for CC Post #13048
Some quick notes:
Could not be more upbeat on prospects
Also, they have no debt, and extend no credit and pay suppliers in advance.
Applications to be put in for listing upgrade in within quarter or so
Sales are going from "millions to tens of millions"
--------------------------------------------------------------------------------
"after 8 yrs...On verge of becoming an overnight success..". Started in 2004..patented after.
Number of shares not appropriate for Nasdaq.. Bring float to appropriate for higher exchange..
With events of revenue and partners interacting.. Fairly large project working on last 3 yrs.. Bringing in upper level managers/logistics.. Going into big boy sandbox..
Francesca..looking at Huge growth point in the company..looking to add 10 times current staff of 7 people based on new contracts.
Wd-40 company worked with him previously. Product Under pressure could be dangerous..
Provides US navy grade protection for corrosion..mold.. Did contract w/ Coates Plc..largest yarn manufacture in world used product in 37 factories world wide.. $1 million in sales. Saves that company 10% per year..
Currently working with several food/pet products manufacturers..
Currently sold by WW Grainger catalog for last 2 years.. Was in agreement with Lowes but too much hassle due to small direct sales orders. Prefers larger OEM companies. Larger contracts will be handled internally but will also sell thru foreign subsidiaries in Latin America, Europe, India, and Middle East.
Profit margins 50% on patented projects.. Revenues currently millions.. Soon to go to tens of millions.. Most of forward revenue done by exec vice president.
Reverse split- will occur.. Possible stock buy back and then reverse split before listing to higher exchange. Possible contact with larger funds in place - very vague in this area..
Super preferred stock-he controls approx xxx super shares.. Company has no debt.. No outstanding credit.. Only money due is salary/loans from the owner and private placement shares.. In Order to keep above 51% die to current pink sheet listing..he had to issue super preferred shares with 1000k to 1 voting rights.. Will not convert his shares with supermajority.. Instead will retire majority of super preferred shares to maintain 51% of control Until he gets on Amex exchange.
Product lasts more than 10 yrs.. Both in cold/Middle East climates.applied like paint brush roller/sprayer.. 53cents per sq foot for residential. $2.50-5.00 per sq ft for industrial. Outdoor life span is 5-10 year.. Indoor applications is 5-10 yrs.
Used in a tool factory on their windows.. Took approx 4 months for company to recover cost. US Navy and 4 US army corp of engineers used the applications..Seattle museum of flight, Pensacola navy measure, l3 communications, Coates Plc textiles.. Currently used on over 100 international textile mills, Galp Energy from Portugal.. Oil pipelines/storage tanks. 55k sq ft of glass windows will use product instead of installing double pane glass.. Same company has another 36 factories in US.
Goal is to move to higher exchange within 2012. Would make applications within a quarter than takes up to 6 months to get the Amex listing.
Less than 12 shareholder own over 1 million shares each.. Total of over 3k shareholders on Noble list..
Currently has 2 global patents.. Already fought off 1 side challenge from a competitor but the competitor lost. Person in china tried to reverse engineer for 1 yr but was not able to figure out process/chemicals.. No competitors on market do not have combined product offering of heat abatement, corrosion, mold/mildew, chemical resistance.. Product is the only uv coating that is clear.. Allows for UV testing as it is clear..All others competitor are white color.
Window coating cannot be measure by r value, but was tested by European Market tests..BTU watts, dropped 34% with standard 3 coat application.since cannot be measured on r va
Ue, cannot qualify for new building energy requirements, but this does not apply to existing buildings.
EPX product for tiles will withstand a blowtorch flame direct for 10 min continuos and is also 97% resistant to sulphuric acid.
Product is breathable at 5 perms..if used on decking than product remains viable as long as it does not peel/chip off.
2011 financials will be out by end of this month (March). No future cash needed for growth due to planned contract growth.
Does not want to be defined only as a "coatings company". New products coming out soon with 2 more products coming out soon (before Amex listing). Will be "energy saving" product. Not currently interested in a no money down revenue/savings share deal with new purchasing companies.
Biggest risk/concern.. Not money..not product.. Biggest concern is hiring right people to,stay w/ company. Current interviewing person to handle logistics for company as this is the biggest roadblock to the future of the company.
Www.Nansulate.com website
Nansulate® Energy Protect Insulation Coating by Industrial Nanotech, Inc. Chosen as a Top Money Saving Pick by BUILDINGS Magazine 04/18 08:00 AM
NAPLES, Fla.--(BUSINESS WIRE)-- Industrial Nanotech, Inc. (INTK:$0.04,00$0.00,000.00%) , an emerging global leader in nanotechnology based energy saving and sustainable solutions is proud to announce that BUILDINGS magazine has selected their patented thermal insulation and mold resistant coating, Nansulate® Energy Protect, as a top 2012 Money-Saving Product. Nansulate® Energy Protect for energy savings and protection of building walls, windows, skylights, and ceilings is part of an elite group of 77 products that will be showcased in the magazine’s June 2012 issue.
Finalists were chosen based on the money-saving qualities offered to building owners and facility managers in areas such as energy consumption, water savings, lighting, envelope improvement, and maintenance.
“We are very honored to have our building energy efficiency product included in the Top Picks by BUILDINGS Magazine,” states Francesca Crolley, VP of Business Development for Industrial Nanotech, Inc. (INTK:$0.04,00$0.00,000.00%) “The award and upcoming June issue feature will help make tens of thousands of building owners and facility managers aware of an effective tool they can utilize for energy savings. The technology in Nansulate® Energy Protect allows building and factory owners to easily coat windows, skylights, interior or exterior walls, ceilings, and ductwork with a translucent paint-on insulation and significantly reduce energy consumption. Customers typically report saving 20% to 40% in heating and cooling costs, plus the product offers other protective benefits including mold and fungi growth resistance, UV resistance, and moisture resistance. The coating can also be used over one of the most significant heat loss culprits... windows. While giving them a slightly frosted look, it allows transmission of approximately 92% of visible light, as tested on pane glass, which offers the ability to daylight a building without giving in to huge energy losses. We believe this product is creating a significant change in the way that existing buildings are insulated and offers an attractive solution for affordable building energy savings.”
According to the U.S. Department of Energy (DOE) buildings account for 40% of U.S. primary energy consumption and 39% of U.S. carbon emissions.
Further information on Nansulate® Energy Protect commercial building insulation coating is available at: www.energyprotect.org.
About BUILDINGS
BUILDINGS serves over 74,000 building owners and professional facilities managers in North America. The monthly publication helps readers make smarter decisions relevant to the management, modernization, and operation of their facilities.
www.buildings.com
About Nansulate®
Nansulate® is the Company's patented product line of award winning, specialty coatings containing a nanotechnology based material and which are well-documented to provide the combined performance qualities of thermal insulation, corrosion prevention, resistance to mold growth, fire resistance, chemical resistance and lead encapsulation in an environmentally safe, water-based, coating formulation. The Nansulate® Product Line includes industrial, residential, agricultural and solar thermal insulation coatings. Additional information about the Company and its products can be found at their websites, (www.inanotk.com) and (www.nansulate.com). Blog: www.nansulate.com/nanoblog, Twitter: www.twitter.com/NanoPioneer, Facebook: www.facebook.com/Nansulate.
About Industrial Nanotech Inc. (INTK:$0.04,00$0.00,000.00%)
Industrial Nanotech Inc. (INTK:$0.04,00$0.00,000.00%) is a global nanoscience solutions and research leader and member of the U.S. Green Building Council. The Company develops and commercializes new and innovative applications for sustainable nanotechnology which are sold worldwide.
Safe Harbor Statement
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic and business conditions, and the ability to attract and retain skilled personnel. The Company is not obligated to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.
Source: Industrial Nanotech, Inc. (INTK:$0.04,00$0.00,000.00%)
Health Enhancement Products, Inc. Expands Intellectual Property Development Effort With Preeminent Research Scientist and Patent Counsel 04/12 08:30 AM
BLOOMFIELD HILLS, MI -- (MARKETWIRE) -- 04/12/12 -- Arizona-based algae producer Health Enhancement Products (HEPI:$0.314,0$-0.0009,-0.29%) has engaged preeminent research scientist Dr. William Gerwick, Distinguished Professor of Oceanography and Pharmaceutical Sciences at the Center for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography and the Skaggs School of Pharmacy and Pharmaceutical Sciences located in the La Jolla campus of the University of California at San Diego.
Dr. Gerwick's current research focuses on the discovery of bioactive molecules with potential anticancer, antibacterial, neurotoxic, antiviral, or anti-inflammatory activity from marine organisms, such as algae. The pathways by which these complex molecules are assembled form the basis of Dr. Gerwick's research, using stable isotope tracer methods and NMR analysis. Many marine algae produce prostaglandin and leukotriene analogs that are strikingly similar to substances produced in the human body, and that have therapeutic value as potential pharmacological agents.
Dr. Gerwick joins an interdisciplinary team that includes scientists from Battelle, the world's largest independent research & development organization. Battelle has recently concluded an in vivo study on behalf of the Company to isolate bioactive test samples. Those samples were derived from a year-long experimentation with fractionation and isolation of potentially active compounds derived from the Company's proprietary algae culture. Dr. Gerwick has been invited to analyze samples that exhibit bioactivity.
Equally significant is an agreement on terms with Dr. Kenneth I. Kohn, patent counsel for Health Enhancement Products (HEPI:$0.314,0$-0.0009,-0.29%) , to develop and manage the Company's intellectual property portfolio on a contingent basis. Dr. Kohn holds a Ph.D. in Pharmacology and Immunology, and provides patent counsel to corporations, universities, research institutes, investors and individuals worldwide. Dr. Kohn prosecutes patent applications in the fields of pharmacology, medicine, chemistry and biotechnology. He also negotiates international licensing agreements and manages intellectual property portfolios for corporate and university clients globally. Dr. Kohn is recognized for his work in patenting Lyrica, a successful anti-inflammatory and anti-seizure therapeutic presently owned by Pfizer.
"It's a great opportunity to get more deeply involved with the development and commercialization of something that can possibly reframe the entire perspective on achieving healthy cholesterol balance," states Dr. Kohn.
Philip M. Rice II, Chief Financial Officer, is heartened by the progress made to date. "We're making steady strides on a wide range of issues," states Mr. Rice. "And, we're looking forward to releasing additional information over the next few weeks."
About Health Enhancement Products, Inc. (HEPI:$0.314,0$-0.0009,-0.29%)
Health Enhancement Products, Inc. (HEPI:$0.314,0$-0.0009,-0.29%) is a health & wellness company engaged in the development of natural products derived from algae cultures for use as dietary supplements and food ingredients. These natural products are extracted from living algae grown in purified water.
Keep in mind, by leaving himself 10% of the super preferred voting stock intact, this is being done as an anti-takeover measure. Without this 10% super preferred stock, he has a minority of shares and could be bought out by a larger coumpany at these give-away prices. Obviously, he wants to shows shareholders his intent to eliminate these shares while maintaining control of the company until these large contracts occur.
Yes it was me
Industrial Nanotech, Inc. Founders Retiring 90% of Their Preferred StockLast update: 3/22/2012 8:23:00 AM
NAPLES, Fla., Mar 22, 2012 (BUSINESS WIRE) -- Industrial Nanotech, Inc. (INTK), an emerging global leader in nanotechnology based energy saving and sustainable solutions announced today that the Co-Founders are retiring ninety percent of their Preferred Stock.
“This is part of an overall strategy to structure Industrial Nanotech, Inc. for potential application to a more senior stock exchange,†stated Stuart Burchill, Co-Founder and CEO/CTO of Industrial Nanotech, Inc. “Based on revenue projections for the upcoming quarters, a result of eight years of diligent effort, it is appropriate to begin execution of a responsible strategy to provide maximum benefit to shareholder value. This is one step in that continuing process.â€
For further information on Nansulate® nanotechnology based coatings and sustainable solutions visit: .
About Nansulate®
Nansulate® is the Company's patented product line of award winning, specialty coatings containing a nanotechnology based material and which are well-documented to provide the combined performance qualities of thermal insulation, corrosion prevention, resistance to mold growth, fire resistance, chemical resistance and lead encapsulation in an environmentally safe, water-based, coating formulation. The Nansulate® Product Line includes industrial, residential, agricultural and solar thermal insulation coatings. Additional information about the Company and its products can be found at their websites, () and (). Blog: , Twitter: , Facebook: .
About Industrial Nanotech Inc.
Industrial Nanotech Inc. is a global nanoscience solutions and research leader and member of the U.S. Green Building Council. The Company develops and commercializes new and innovative applications for sustainable nanotechnology which are sold worldwide.
Safe Harbor Statement
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic and business conditions, and the ability to attract and retain skilled personnel. The Company is not obligated to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.
SOURCE: Industrial Nanotech, Inc.
Industrial Nanotech, Inc. Francesca Crolley, US & Canada: 800-767-3998 investini@inanotk.com International: +1 239-254-0346
Copyright Business Wire 2012
Some quick notes:
Could not be more upbeat on prospects
Also, they have no debt, and extend no credit and pay suppliers in advance.
Applications to be put in for listing upgrade in within quarter or so
Sales are going from "millions to tens of millions"
--------------------------------------------------------------------------------
"after 8 yrs...On verge of becoming an overnight success..". Started in 2004..patented after.
Number of shares not appropriate for Nasdaq.. Bring float to appropriate for higher exchange..
With events of revenue and partners interacting.. Fairly large project working on last 3 yrs.. Bringing in upper level managers/logistics.. Going into big boy sandbox..
Francesca..looking at Huge growth point in the company..looking to add 10 times current staff of 7 people based on new contracts.
Wd-40 company worked with him previously. Product Under pressure could be dangerous..
Provides US navy grade protection for corrosion..mold.. Did contract w/ Coates Plc..largest yarn manufacture in world used product in 37 factories world wide.. $1 million in sales. Saves that company 10% per year..
Currently working with several food/pet products manufacturers..
Currently sold by WW Grainger catalog for last 2 years.. Was in agreement with Lowes but too much hassle due to small direct sales orders. Prefers larger OEM companies. Larger contracts will be handled internally but will also sell thru foreign subsidiaries in Latin America, Europe, India, and Middle East.
Profit margins 50% on patented projects.. Revenues currently millions.. Soon to go to tens of millions.. Most of forward revenue done by exec vice president.
Reverse split- will occur.. Possible stock buy back and then reverse split before listing to higher exchange. Possible contact with larger funds in place - very vague in this area..
Super preferred stock-he controls approx xxx super shares.. Company has no debt.. No outstanding credit.. Only money due is salary/loans from the owner and private placement shares.. In Order to keep above 51% die to current pink sheet listing..he had to issue super preferred shares with 1000k to 1 voting rights.. Will not convert his shares with supermajority.. Instead will retire majority of super preferred shares to maintain 51% of control Until he gets on Amex exchange.
Product lasts more than 10 yrs.. Both in cold/Middle East climates.applied like paint brush roller/sprayer.. 53cents per sq foot for residential. $2.50-5.00 per sq ft for industrial. Outdoor life span is 5-10 year.. Indoor applications is 5-10 yrs.
Used in a tool factory on their windows.. Took approx 4 months for company to recover cost. US Navy and 4 US army corp of engineers used the applications..Seattle museum of flight, Pensacola navy measure, l3 communications, Coates Plc textiles.. Currently used on over 100 international textile mills, Galp Energy from Portugal.. Oil pipelines/storage tanks. 55k sq ft of glass windows will use product instead of installing double pane glass.. Same company has another 36 factories in US.
Goal is to move to higher exchange within 2012. Would make applications within a quarter than takes up to 6 months to get the Amex listing.
Less than 12 shareholder own over 1 million shares each.. Total of over 3k shareholders on Noble list..
Currently has 2 global patents.. Already fought off 1 side challenge from a competitor but the competitor lost. Person in china tried to reverse engineer for 1 yr but was not able to figure out process/chemicals.. No competitors on market do not have combined product offering of heat abatement, corrosion, mold/mildew, chemical resistance.. Product is the only uv coating that is clear.. Allows for UV testing as it is clear..All others competitor are white color.
Window coating cannot be measure by r value, but was tested by European Market tests..BTU watts, dropped 34% with standard 3 coat application.since cannot be measured on r va
Ue, cannot qualify for new building energy requirements, but this does not apply to existing buildings.
EPX product for tiles will withstand a blowtorch flame direct for 10 min continuos and is also 97% resistant to sulphuric acid.
Product is breathable at 5 perms..if used on decking than product remains viable as long as it does not peel/chip off.
2011 financials will be out by end of this month (March). No future cash needed for growth due to planned contract growth.
Does not want to be defined only as a "coatings company". New products coming out soon with 2 more products coming out soon (before Amex listing). Will be "energy saving" product. Not currently interested in a no money down revenue/savings share deal with new purchasing companies.
Biggest risk/concern.. Not money..not product.. Biggest concern is hiring right people to,stay w/ company. Current interviewing person to handle logistics for company as this is the biggest roadblock to the future of the company.
Www.Nansulate.com website
FORM 8-K
Current Report Pursuant
to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) January 26, 2012
Health Enhancement Products, Inc.
(Exact Name Of Registrant As Specified In Its Charter)
Nevada
(State or Other Jurisdiction of Incorporation)
000-30415
87-0699977
(Commission File Number)
(I.R.S. Employer Identification No.)
7 West Square Lake Rd., Bloomfield Hills, MI
48302
(Address of Principal Executive Offices)
(Zip Code)
(248) 452 9866
(Registrant’s Telephone Number, Including Area Code)
N/A
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
.
Communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
.
Material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
.
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
.
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
--------------------------------------------------------------------------------
Item 1.01.
Entry into a Material Definitive Agreement
Item 2.03
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Entry into a Material Definitive Agreement
Creation of a Direct Financial Obligation
On January 27, 2012, the Registrant and The Venture Group, LLC, a Maryland limited liability company (“Venture Group”), entered into the following documents , effective as of January 26, 2012: (i) a Subscription Agreement under which the Lender has agreed to advance $500,000 to the Registrant, as follows: $332,000 on January 26, 2012, which advance has been made, and $168,000 by February 3, 2012, (ii) a Subordinated Convertible Promissory Note in the principal amount of $500,000 (“Note”); (iii) (a) a Security Agreement, under which the Registrant granted the Lender a subordinated security interest in all of its assets and (b) an IP security agreement under which the Registrant granted the Lender a subordinated security interest in all its intellectual properties, including patents, to secure its obligations to the Lender under the Note and related documents; (iv) a Termination and Mutual Release Agreement under which the Registrant and Venture Group terminated their prior agreements and released each other from any liability, including liabilities related to the financing agreements they previously executed (See Form 8-K current Report dated 12/02/2011); and (v) a Termination and Release Agreement under which the Registrant and Oxford Holdings, LLC terminated their prior agreement and Oxford Holdings released the Registrant from any liability, including liabilities related to the agreement they previously executed. The Registrant also acknowledged an intercreditor agreement between Venture Group and HEP Investments, LLC, the Registrant’s senior secured lender.
In addition, the Registrant has agreed to issue the Lender warrants to purchase an aggregate of 833,333 shares of common stock at an exercise price of $.12 per share, for a term of three years. The Warrants are issuable to the Lender pro rata based on the amount invested in relation to the total investment amount (about 166,667 warrants per $100,000 invested).
Amounts advanced under the Note are (i) secured on a subordinated basis by all the Registrant’s assets, (ii) convertible into the Registrant’s restricted common stock at $.12 per share, (iii) bear interest at the rate of 11% per annum (payable on the first and second anniversary of the Note (unless earlier paid off), in cash or stock, at the Registrant’s option), and (iv) unpaid principal not previously converted into common stock must be repaid on the second anniversary of the Note (01/26/2014). The Note may be prepaid upon thirty days written notice, but not before August 31, 2012, provided that in the event of prepayment, the Registrant must pay the Lender an additional 5% of the outstanding principal amount.
The Registrant has agreed to pay the following aggregate fees to Oxford Holdings, LLC in connection with the Loan transaction (assuming the full $500,000 is received): (i) finder’s fees of approximately $27,600 in cash, (ii) warrants to purchase 200,000 shares of common stock at an exercise price of $.15 per share for a term of two years, and (iii) a $15,000 non-accountable expense allowance. In addition, The Registrant has agreed to pay Venture Group $10,000 in cash in payment of the Venture Group’s legal fees. If less than the full $500,000 is received, the fees are subject to proration based on the amount actually invested in proportion to the total amount committed ($500,000).
Item 8.01 Other Events
License Agreement with Zus Health, LLC/Ceptazyme, LLC
On January 9, 2012, the Registrant notified Ceptazyme LLC (i) that there was no agreement between the Registrant and Ceptazyme, as the Registrant had not approved any assignment of the License Agreement by Zus Health to Ceptazyme and (ii) that, even if there had been a valid assignment to Ceptazyme, Ceptazyme had committed multiple material breaches of the agreement. The Registrant believes that Ceptazyme, LLC (i) has failed to market the Registrant’s product in a manner compliant with state and federal regulations, and (ii) that it allowed its distributors to make claims and representations that were not in compliance with applicable regulations, among many other breaches.
Based on the foregoing, the Registrant filed a lawsuit in Michigan against Zus Health and Ceptazyme on January 16, 2012, alleging breach of contract. Subsequently, Ceptazyme filed suit in Utah against the Registrant on January 24, 2012, also alleging, breach of contract.
The Registrant intends to prosecute and defend this matter vigorously.
Item 9.01 Financial Statements and Exhibits
N/A
2
--------------------------------------------------------------------------------
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: January 31, 2012
HEALTH ENHANCEMENT PRODUCTS, INC.
By /s/ Philip M. Rice, II
Philip M. Rice, II, Chief Financial Officer
January 25, 2012 - 05:30 AM PST
Health Enhancement Products, Inc. Launches New Website and Toll-Free Phone Service
SCOTTSDALE, AZ -- (Marketwire) -- 01/25/12 -- Arizona-based algae producer Health Enhancement Products (OTCBB: HEPI) has launched a new temporary website, signaling its new focus on research-based products for the dietary supplement, food ingredient and medical foods markets. The new URL is -- www.health-enhancement-products.com and the new toll-free phone number is (888) 871-6903. The Michigan local phone number for administration and billing is now (248) 397-4300.
The website is temporary in nature, providing basic information regarding the Company's new direction. A permanent website with additional features will be largely in place within the next 45 days, according to Health Enhancement CEO Andrew Dahl.
Also, due to unanticipated interest in last week's investor conference call, the call-in lines were temporarily overwhelmed and some interested parties where unable to connect. The Company apologizes for the inconvenience and advises those who are interested in hearing the conference call to dial (877) 870-5176 and press 4505436 to access the recording. Access to the recording will be available until end of business, January 31, 2012.
Finally, the Company will be upgrading its corporate identity and updating corporate communications over the next two months.
About Health Enhancement Products, Inc.
Health Enhancement Products, Inc. (OTCBB: HEPI) is a health & wellness company engaged in the research and development of natural products derived from algae cultures for use as dietary supplements and food ingredients. These natural products are extracted from living algae grown in purified water.
Safe Harbor Statement
Except for any historical information, the matters discussed in this press release contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements involve risks and uncertainties. A number of factors could cause actual results to differ from those indicated in the forward-looking statements, including the timing of completion of a trial, actual future clinical trial results being different than the results the company has obtained to date, and the company's ability to secure funding. Such statements are subject to a number of assumptions, risks and uncertainties. Readers are cautioned that such statements are not guarantees of future performance and those actual results or developments may differ materially from those set forth in the forward-looking statements. The company undertakes no obligation to publicly update or revise forward-looking statements, whether as a result of new information or otherwise.
REMINDER:
Health Enhancement Products, Inc. Schedules Investor Conference Call at 11:00AM EST on Tuesday, January 17, 2012
Press Release: Health Enhancement Products, Inc. – Tue, Jan 10, 2012 8:30 AM EST
RELATED QUOTES
Symbol Price Change
HEPI.OB 0.27 0.00
BLOOMFIELD HILLS, MI--(Marketwire -01/10/12)- Arizona-based algae producer Health Enhancement Products (OTC.BB: HEPI.OB - News) has scheduled a conference call open to investors and other interested parties at 11:00AM Eastern Standard Time on Tuesday, January 17, 2012. The call will be conducted by incoming CEO Andrew Dahl. The format for the call is basic -- a prepared statement by HEPI President & CEO Andrew Dahl, followed by a 20-minute Q&A session when Mr. Dahl takes questions from callers.
"As new management steps in, we want to schedule regular communication with shareholders and the investment community at large," states Dahl. "In addition to quarterly conference calls and press releases for breaking news, we are also preparing to revamp the corporate website and re-focus its content."
Topics for the conference call will include statements regarding recent changes to the board, the move of administrative functions from Arizona to Michigan, and updates to the progress of scientific research at Battelle, along with new strategies for future product applications.
Callers will be encouraged to submit questions for the Q&A session that follows prepared remarks.
11:00AM Eastern Standard Time, January 17 2012.
Participant Dial-In Numbers:
TOLL-FREE 1-877-941-4774
TOLL/INTERNATIONAL 1-480-629-9760
About Health Enhancement Products, Inc.
Health Enhancement Products, Inc. (OTC.BB: HEPI.OB - News) is a health & wellness company engaged in the development of natural products derived from algae cultures for use as dietary supplements and food ingredients. These natural products are extracted from living algae grown in purified water.
Safe Harbor Statement
Except for any historical information, the matters discussed in this press release contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements involve risks and uncertainties. A number of factors could cause actual results to differ from those indicated in the forward-looking statements, including the timing of completion of a trial, actual future clinical trial results being different than the results the company has obtained to date, and the company's ability to secure funding. Such statements are subject to a number of assumptions, risks and uncertainties. Readers are cautioned that such statements are not guarantees of future performance and those actual results or developments may differ materially from those set forth in the forward-looking statements. The company undertakes no obligation to publicly update or revise forward-looking statements, whether as a result of new information or otherwise
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report Pursuant
to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) January 12, 2012
Health Enhancement Products, Inc.
(Exact Name Of Registrant As Specified In Its Charter)
Nevada
(State or Other Jurisdiction of Incorporation)
000-30415
87-0699977
(Commission File Number)
(I.R.S. Employer Identification No.)
7 West Square Lake Rd., Bloomfield Hills, MI
48302
(Address of Principal Executive Offices)
(Zip Code)
(248) 452 9866
(Registrant’s Telephone Number, Including Area Code)
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:
.
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
.
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
.
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
.
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
--------------------------------------------------------------------------------
Item 8.01 Other Events
As disclosed in Form 8-K Current Reports filed December 20, 2011 and January 6, 2012, Health Enhancement Products Inc. (the “Company”) has revamped its management team, bringing in a new director, President and CFO. Andrew Dahl, the Company’s new President, was the lead consultant at Great Northern & Reserve Partners, the Company’s former business consultant.
The Company’s new management team has been assessing the Company’s business strategy and certain of its contractual relationships in the context of the regulatory environment in which the Company is currently operating. Based on this review, the Company has determined to move forward with a research-based product development program. In connection with its assessment, the Company has determined that there have been multiple material breaches by Zus Health, LLC (as well as its purported assignee) of its License Agreement with the Company dated September 2, 2010. Accordingly, the Company has served notice of these material breaches upon Zus and its purported assignee. The Company does not believe that it can cost effectively sell and distribute its current product given regulatory and production considerations. Accordingly, the Company intends to implement a research-based product development program, as more fully explained below.
The Company is committed to evolving new products, derived from its portfolio of bioactive natural isolates (groups of related molecules). The Company anticipates that these products will be better suited for large-scale production and compliance with new and anticipated federal regulations for dietary supplements, food ingredients and medical applications. New research indicates that production technologies previously developed by others can be adapted to make more product with improved consistency and greater positive benefits, all at lower cost. Accordingly, the Company believes it inadvisable to expend more money and time on the current production methodology, given the complexity of the process and the cost of production and compliance. The Company will pursue product development strategies based on ongoing research conducted at contracted research facilities.
The plan embodies a new business model for the Company – instead of attempting to generate revenue and profit from the sale of a single product for individual use, the Company intends to derive its future income from licensing or selling natural bioactive ingredients, derived from its algae cultures, to much larger, better-financed food, dietary supplement and medical food manufacturers.
The Company anticipates income streams will be generated from (i) royalties and option payments for licensed natural bioactive ingredients and (ii) bulk sales of such ingredients to food, dietary supplement and medical food processors and/or marketers. The Company expects contract ingredient manufacturers will produce these bulk ingredients for sale by the Company.
This strategy should allow the Company to drive revenue without sizeable capital outlays, facility build-outs, large staffs and the attendant increases in execution risk. The largest anticipated expenses would be research and product development. The Company could use its existing facility in Arizona as a source for research feedstock and clinical studies. This overall approach would enable the Company to contain its overhead. Under this new business strategy, the Company is expected to become in essence a licensor of intellectual property on a larger scale, and not a producer of natural products to be sold one bottle at a time. The loss in revenue from sales of existing product is inconsequential. In general, in any given month, less than $10,000 worth of goods was sold, while the Company generated approximately $100,000 in negative operating cash flows.
Finally, the Company is also investigating the potential for synthetic molecules derived from the natural bioactive isolates. These synthetic molecules have the potential to be licensed or sold as lead compounds for new drug development programs conducted by others. However, this is a long-term proposition where any possible revenues, as significant as they might be, must be discounted against very long developmental lead times and the possibility of failure in a future clinical trial. In spite of these risks, subject to the receipt of necessary funding, which the Company does not currently have, the Company intends to proceed with a synthetic program because the potential revenues from a successful drug development are large.
In summary, although the change of business model will affect revenues, such revenues have been inconsequential. Instead of continuing the a business model which has generated substantial operating losses over a number of years, the Company is reoriented into an exclusive R&D mode with anticipated future revenues to be generated through licensing of intellectual property and reselling of licensed, contract manufactured ingredients.
2
--------------------------------------------------------------------------------
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: January 12, 2012
HEALTH ENHANCEMENT PRODUCTS, INC.
By /s/Philip M. Rice, II
Philip M. Rice, II, Chief Financial Officer
Health Enhancement Products, Inc. Schedules Investor Conference Call at 11:00AM EST on Tuesday, January 17, 2012 01/10 08:30 AM
BLOOMFIELD HILLS, MI -- (MARKETWIRE) -- 01/10/12 -- Arizona-based algae producer Health Enhancement Products (HEPI:$0.21,00$-0.02,00-8.70%) has scheduled a conference call open to investors and other interested parties at 11:00AM Eastern Standard Time on Tuesday, January 17, 2012. The call will be conducted by incoming CEO Andrew Dahl. The format for the call is basic -- a prepared statement by HEPI President & CEO Andrew Dahl, followed by a 20-minute Q&A session when Mr. Dahl takes questions from callers.
"As new management steps in, we want to schedule regular communication with shareholders and the investment community at large," states Dahl. "In addition to quarterly conference calls and press releases for breaking news, we are also preparing to revamp the corporate website and re-focus its content."
Topics for the conference call will include statements regarding recent changes to the board, the move of administrative functions from Arizona to Michigan, and updates to the progress of scientific research at Battelle, along with new strategies for future product applications.
Callers will be encouraged to submit questions for the Q&A session that follows prepared remarks.
11:00AM Eastern Standard Time, January 17 2012.
Participant Dial-In Numbers:
TOLL-FREE 1-877-941-4774
Health Enhancement Products, Inc. Closes on New Capital Funding to Accelerate Research and Product Development 12/06 10:41 AM
SCOTTSDALE, AZ -- (MARKETWIRE) -- 12/06/11 -- The board directors of Health Enhancement Products, Inc. (HEPI:$0.178,0$0.000,00.00%) an Arizona-based food ingredients and nutraceutical enterprise, has accepted a $2 million convertible debt agreement to fund the Company's R&D efforts going forward. In light of progress being made with its research partners, the capital raise was necessary to maintain the pace and scope of work underway.
The funding has been made available by HEP Investments LLC, a private investment group based in Michigan. The first tranche of $500,000 was deposited Monday, December 5. The intended use of such funds is focused primarily on advancing work in cholesterol regulation and anti-inflammatory applications.
"We are very pleased that the Company was able to secure funding on reasonable terms and within reasonable expectations," states Health Enhancement board chairman Stephen J. Warner. "This will allow us to execute a coherent strategy and move decisively to take advantage of market opportunities as product applications are more fully developed."
The funding comes at a time when the Company is expanding its research and product development work into four discrete market verticals, details of which will be forthcoming in the next several weeks.
"The capital raise is another step in the right direction," says Health Enhancement Chief Financial Officer Phillip M. Rice II. "We will be able to marshal resources to their greatest effect and expect to see acceleration in the R&D process."
About Health Enhancement Products, Inc. (HEPI:$0.178,0$0.000,00.00%)
Health Enhancement Products, Inc. (HEPI:$0.178,0$0.000,00.00%) is a health & wellness company engaged in the development of natural products derived from algae cultures for use as dietary supplements and food ingredients. These natural products are extracted from living algae grown in purified water.
Safe Harbor Statement
Except for any historical information, the matters discussed in this press release contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements involve risks and uncertainties. A number of factors could cause actual results to differ from those indicated in the forward-looking statements, including the timing of completion of a trial, actual future clinical trial results being different than the results the company has obtained to date, and the company's ability to secure funding. Such statements are subject to a number of assumptions, risks and uncertainties. Readers are cautioned that such statements are not guarantees of future performance and those actual results or developments may differ materially from those set forth in the forward-looking statements. The company undertakes no obligation to publicly update or revise forward-looking statements, whether as a result of new information or otherwise.
Contact:
IR
David Sasso
954-990-5451
Health Enhancement Products, Inc. Expands Scientific Inquiry at Battelle as Isolated Molecules Are Tested for Bioactivity 11/18 08:30 AM
SCOTTSDALE, AZ -- (MARKETWIRE) -- 11/18/11 -- The board directors of Health Enhancement Products, Inc. (HEPI:$0.15,00$0.01,007.14%) , a Scottsdale, AZ-based food ingredients and nutraceutical enterprise, has authorized an expanded study of its algae extracts. Since May of 2011, the Company has been working with Battelle, the world's largest independent research and development organization, to isolate the active molecules in its proprietary algae extract, specifically those natural compounds responsible for supporting a healthy cholesterol balance. Over the intervening months, Battelle research scientists have conducted a series of experiments to separate bioactive fractions of the algae extract in order to isolate and further characterize the bioactive components.
That program has resulted in a number of isolates that can now be tested in vivo. The in vivo portion of this expanded research project will be carried out in several steps. The in vivo study is expected to commence in several days. The isolated samples will be administered to test subjects over the course of 30 days, after which an evaluation process would identify those samples with bioactivity. Battelle scientists would subject those samples to further refinement and validation, or proceed directly to a final analysis.
In February of 2011, Health Enhancement had filed a global PCT patent application specifically detailing the method of cholesterol regulation. In October of 2010, the Company had been issued a US patent for its unique and novel method of extracting the active compounds from its proprietary algae culture. The Company expects to file several additional patent applications in the next two months to protect its growing intellectual property portfolio.
"Health Enhancement Products (HEPI:$0.15,00$0.01,007.14%) is committed to seeing this research program through to its ultimate conclusion," states board chairman Stephen Warner. "Following the anticipated success of this research work, we expect to embark on a product development program to establish marketable applications for the derivatives of these natural products."
The Company intends to move forward with a product development plan created by consulting group Great Northern & Reserve Partners. Details of the plan will be released as specific benchmarks and milestones are reached over the course of the next few months.
Philip M. Rice II, the Company's newly appointed Chief Financial Officer, is pleased with the new developments. "We're entering a new era," states Mr. Rice. "The process of managing the research and funding its progress are being streamlined and re-focused. We can look forward to a regular timetable of announcements and real progress on several fronts."
About Health Enhancement Products, Inc. (HEPI:$0.15,00$0.01,007.14%)
Health Enhancement Products, Inc. (HEPI:$0.15,00$0.01,007.14%) is a health & wellness company engaged in the development of natural products derived from algae cultures for use as dietary supplements and food ingredients. These natural products are extracted from living algae grown in purified water.
About Battelle
As the world's largest independent research and development organization, Battelle provides innovative solutions to the world's most pressing needs through its four global businesses: Laboratory Management; National Security; Health and Life Sciences; and Energy, Environment, and Material Sciences. It advances scientific discovery and application by conducting $6.5 billion in global R&D annually through contract research, laboratory management, and technology commercialization. Headquartered in Columbus, Ohio, Battelle oversees 22,000 employees in more than 130 locations worldwide, including seven national laboratories which Battelle manages or co-manages for the U.S. Department of Energy and the U.S. Department of Homeland Security and a nuclear energy lab in the United Kingdom.
Battelle also is of the nation's leading charitable trusts focusing on societal and economic impact and actively supporting and promoting science, technology, engineering, and mathematics (STEM).
Safe Harbor Statement
Except for any historical information, the matters discussed in this press release contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements involve risks and uncertainties. A number of factors could cause actual results to differ from those indicated in the forward-looking statements, including the timing of completion of a trial, actual future clinical trial results being different than the results the company has obtained to date, and the company's ability to secure funding. Such statements are subject to a number of assumptions, risks and uncertainties. Readers are cautioned that such statements are not guarantees of future performance and those actual results or developments may differ materially from those set forth in the forward-looking statements. The company undertakes no obligation to publicly update or revise forward-looking statements, whether as a result of new information or otherwise.
Contact:
IR
David Sasso
954-990-5451
Industrial Nanotech, Inc. Announces Use of Nansulate® Liquid Insulation By Federal Bureau of Prisons 11/14 08:00 AM
NAPLES, Fla.--(BUSINESS WIRE)-- Industrial Nanotech, Inc. (INTK:$0.0220,$0.0000,0.00%) , an emerging global leader in nanoscience energy saving solutions, announced today that the Company’s Nansulate® patented thermal insulation and protective coatings are in use by Federal Bureau of Prisons facilities. Applications for the coatings include steam pipe insulation, duct insulation, and heat exchanger insulation. The coatings are a nanotechnology based liquid form of insulation that offers a cost effective environmentally responsible solution for reducing energy costs. Advantages for insulation and surface protection include low VOC, easy to apply, non-toxic and cannot be torn and cause debris because it is a clear coating that adheres directly to the surface. Nansulate® also provides mold resistance, corrosion resistance, and ease of installation with a brush, roller or paint sprayer.
“We’ve worked with several correctional facilities recently to assist them with insulation that will meet their safety and environmental standards,” stated Francesca Crolley, V.P. Business Development for Industrial Nanotech, Inc. (INTK:$0.0220,$0.0000,0.00%) “Nansulate offers a unique benefit to prison environments. It is a clean, clear, water-based insulation that adheres and conforms to the surface of the duct, pipe or equipment and offers added safety in this type of environment. In addition to insulation, it also reduces hot surface temperatures to a safe touch range and increases the longevity of equipment by providing corrosion protection and moisture resistance. We are pleased to be providing a next generation technology to the prison industry that offers a great value for long-term performance.”
The Federal Bureau of Prisons was established in 1930 to provide more progressive and humane care for Federal inmates, to professionalize the prison service, and to ensure consistent and centralized administration. Today, the Bureau consists of 117 institutions, 6 regional offices, a Central Office (headquarters), 2 staff training centers, and 22 community corrections offices
About Nansulate®
Nansulate® is the Company's patented product line of award winning, specialty coatings containing a nanotechnology based material and which provide the combined performance qualities of thermal insulation, corrosion prevention, resistance to mold growth, fire resistance, chemical resistance and lead encapsulation in an environmentally safe, water-based, coating formulation. Nansulate® products are made in the USA. Additional information about the Company and its products can be found at their websites, (www.industrial-nanotech.com) and (www.nansulate.com). Blog: www.nansulate.com/nanoblog, Twitter: www.twitter.com/NanoPioneer, Facebook: www.facebook.com/Nansulate.
About Industrial Nanotech Inc. (INTK:$0.0220,$0.0000,0.00%)
Industrial Nanotech Inc. (INTK:$0.0220,$0.0000,0.00%) is a global nanoscience solutions and research leader and member of the U.S. Greenbuilding Council and an official ALLY organization with the U.S. Dept. of Energy "Save Energy Now" program. The Company develops and commercializes new and innovative applications for sustainable nanotechnology which are sold worldwide.
Safe Harbor Statement
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic and business conditions, and the ability to attract and retain skilled personnel. The Company is not obligated to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.
Source: Industrial Nanotech, Inc. (INTK:$0.0220,$0.0000,0.00%)
Health Enhancement Products, Inc. Appoints New Chief Financial Officer 11/03 08:30 AM
SCOTTSDALE, AZ -- (MARKETWIRE) -- 11/03/11 -- The board directors of Health Enhancement Products, Inc. (HEPI:$0.17,00$0.00,000.00%) a Scottsdale, AZ based food ingredients and nutraceutical enterprise, has appointed Philip M. Rice, II as Chief Financial Officer. Mr. Rice is managing principal and founder of Legacy Results, a Michigan-based consulting firm. Prior to founding Legacy Results in 2001, Mr. Rice served as Chief Operating Officer of Stahl's Inc., Chief Financial Officer of Gallagher-Kaiser Corp., and President and CFO of Speedy International, Inc.
Philip Rice began his professional career at Deloitte & Touche where he became a Certified Public Accountant (CPA) in 1979. He has facilitated business transactions in North America, Europe, Asia, Central and South America for various private and publicly-held corporations.
Mr. Rice serves on several private company advisory boards and is a member of the Michigan Association of CPAs and the American Institute of CPAs.
"We are pleased that Phil Rice has accepted this position," states board chairman Stephen Warner. "He will no doubt bring great value and credibility to the Company as he institutes more sophisticated financial controls and reporting. We are eager to move forward with plans to recast the organizational structure of HEPI in advance of expected growth in scope and revenues."
About Health Enhancement Products, Inc. (HEPI:$0.17,00$0.00,000.00%)
Health Enhancement Products, Inc. (HEPI:$0.17,00$0.00,000.00%) is a health & wellness company engaged in the development of a product comprised of pure, all-natural compounds that can be used as a dietary supplement and food additive. The Company's product is ProAlgaZyme® (PAZ™), a liquid product drawn from living algae grown in purified water. The water in which the algae are grown is drawn off, filtered and bottled under the trademark ProAlgaZyme®.
Safe Harbor Statement
Except for any historical information, the matters discussed in this press release contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements involve risks and uncertainties. A number of factors could cause actual results to differ from those indicated in the forward-looking statements, including the timing of completion of a trial, actual future clinical trial results being different than the results the company has obtained to date, and the company's ability to secure funding. Such statements are subject to a number of assumptions, risks and uncertainties. Readers are cautioned that such statements are not guarantees of future performance and those actual results or developments may differ materially from those set forth in the forward-looking statements. The company undertakes no obligation to publicly update or revise forward-looking statements, whether as a result of new information or otherwise.
IR Contact:
David Sasso
954-990-5451
Battelle Memorial InstituteFrom Wikipedia, the free encyclopedia
Jump to: navigation, search
Battelle Memorial Institute
Type Private Nonprofit Charitable Trust
Industry Business Services
Founded Columbus, Ohio (1929)
Headquarters Columbus, Ohio
Key people Jeffrey Wadsworth, President and CEO
Products Technical & Scientific Research Services
Revenue $4.9 billion USD[1]
Employees 22,000
Website http://www.battelle.org
Headquarters in ColumbusBattelle Memorial Institute is a private nonprofit applied science and technology development company headquartered in Columbus, Ohio. Battelle is a charitable trust organized as a nonprofit corporation under the laws of the State of Ohio and is exempt from taxation under Section 501(c)(3) of the Internal Revenue Code because it is organized for charitable, scientific and education purposes. The institute opened in 1929 but traces its origins to the 1923 will of Ohio industrialist Gordon Battelle which provided for its creation. Originally focusing on contract research and development work in the areas of metals and material science, Battelle is now an international science and technology enterprise that explores emerging areas of science, develops and commercializes technology, and manages laboratories for customers.
Contents [hide]
1 Business
2 National laboratory management
3 Technological and medical advances
4 See also
5 References
6 External links
[edit] BusinessBattelle has three business divisions:
National Security – Chemical, Biological, Radiological, Nuclear and Explosive (CBRNE) technologies, Aerospace, Maritime and Ground Systems, Environmental Systems and Energetic Systems.
Energy, Environment and Material Sciences – Battelle provides solutions for challenges in multiple markets, including Oil, Gas and Coal Mining; Industrial and Consumer Products; Alternative Energy; Government and Regulatory; and Utilities.
Health and Life Sciences – Safety and efficacy in the advancement of therapeutics, diagnostics, vaccines, technology enhancement and crop science; Public Health and Environmental Health Research and Evaluation and medical device solutions.
Battelle contributes to education initiatives in Ohio and elsewhere in the United States, especially in the science, technology, engineering, and mathematics (STEM) disciplines. Contributions range from a million dollar donation to the National Society of Black Engineers to building Metro High School in conjunction with The Ohio State University.
In addition to its Columbus (Ohio) headquarters, Battelle has offices Aberdeen (Maryland), West Jefferson (Ohio), Dublin (Ohio), Sequim (Washington), Arlington (Virginia), Duxbury (Massachusetts) and Charlottesville (Virginia).[2]
[edit] National laboratory managementIn addition to operating three of its own research facilities, as of 2010, Battelle manages or co-manages on behalf of the United States Department of Energy the following national laboratories:
Brookhaven National Laboratory (through Brookhaven Science Associates, LLC – a collaboration between Battelle and Stony Brook University)
Idaho National Laboratory (through the Battelle Energy Alliance – a collaboration between Battelle, BWX Technologies, Inc., Washington Group International, Electric Power Research Institute and an alliance of universities)
National Renewable Energy Laboratory (in partnership with Midwest Research Institute)
Oak Ridge National Laboratory (through UT-Battelle, LLC – a collaboration between Battelle and the University of Tennessee)
Pacific Northwest National Laboratory
Lawrence Livermore National Laboratory (through Lawrence Livermore National Security, LLC – a collaboration between Battelle, BWX Technologies, Inc., Washington Group International, the University of California, Bechtel National, and The Texas A&M University System)
Additionally, on behalf of the Department of Homeland Security:
National Biodefense Analysis and Countermeasures Center
[edit] Technological and medical advances
View of Columbus facilities from King Ave.In the 1940s, Battelle's Vice-President of Engineering, John Crout made it possible for Battelle researchers, including William Bixby and Paul Andrus, to develop Chester Carlson's concept of dry copying. Carlson had been turned down for funding by more than a dozen agencies including the U.S. Navy. Work led to the first commercial xerographic equipment, and to the formation of Xerox corporation.
Battelle also developed the first nuclear fuel rods for nuclear reactors, numerous advances in metallurgy that helped advance the United States space program, algorithms and coatings that led to the first optical digital recorder developed by James Russell, which paved the way for the first compact disc, and the first generation jet engines using titanium alloys.[3]
Other advances included the armor plating for tanks in World War II, Snopake, the first correction fluid, developed in 1955; the fuel for the first nuclear submarine, the Nautilus; development of the Universal Product Code in 1965, cruise control for automobiles in 1970, and the first all-sputtered photovatic cell for solar energy in 1974. In 1987, PIRI, a fiber-optics venture with Mitsubishi and NTT, was launched, which resulted in a $1.8 billion market. A fun note, in conjunction with Kevin M. Amula, Battelle Geneva developed "No-melt" chocolate in 1988.
Battelle has made numerous medical advances, including a reusable insulin injection pen developed with Eli Lilly and Co. recently, and in 1972 had a breakthrough with the development of special tubing to prevent blood clots during surgical procedures.[4]
Health Enhancement Products, Inc. Contracts Battelle in a Final Drive to Develop Dietary Supplement and Pharmaceutical Market Programs 05/31 08:30 AM
SCOTTSDALE, AZ -- (MARKET WIRE) -- 05/31/11 -- Health Enhancement Products, Inc. (HEPI:$0.18,00$0.00,000.00%) has executed the first phase of a multi-phase R&D contract with Columbus, Ohio-based Battelle to refine, analyze and potentially synthesize the active molecules derived from its proprietary algal extracts. These active molecules were the focus of the Company's most recent formal patent application, submitted to the USPTO several weeks ago, and are believed to be responsible for the reduction in LDL cholesterol and increase in HDL cholesterol in test subjects. Over the past two years, Health Enhancement has been conducting a variety of tests, studies and analyses to fully substantiate the efficacy of the active molecules and to verify their unique method of cholesterol regulation, among other healthful properties.
One of the greatest challenges has been the isolation of the active molecules in sufficient quantity to conduct further research and development. That obstacle has been overcome in part at Oxford Biomedical Research, based in Rochester Hills, Michigan, through process refinements that the Company considers highly confidential and proprietary. Those process refinements will then help guide Battelle researchers as they scale up the volume of the active molecules to be extracted from the test samples.
Armed with that information, Health Enhancement principals can more precisely address the nutraceutical and dietary supplement markets with targeted applications for its naturally-derived bioactive extracts.
About Health Enhancement Products, Inc. (HEPI:$0.18,00$0.00,000.00%)
Health Enhancement Products, Inc. (HEPI:$0.18,00$0.00,000.00%) is a health & wellness company engaged in the development of algal-based products that can be used as dietary supplements and food additives. The Company's portfolio of cultures and production processes has generated bioactive products for focused health applications.
About Battelle
As the world's largest independent research and development organization, Battelle provides innovative solutions to the world's most pressing needs through its four global businesses: Laboratory Management; National Security; Health and Life Sciences; and Energy, Environment and Material Sciences. It advances scientific discovery and application by conducting $6.5 billion in global R&D annually through contract research, laboratory management and technology commercialization. Headquartered in Columbus, Ohio, Battelle oversees 22,000 employees in more than 130 locations worldwide, including seven national laboratories which Battelle manages or co-manages for the U.S. Department of Energy and the U.S. Department of Homeland Security and a nuclear energy lab in the United Kingdom.
Battelle also is one of the nation's leading charitable trusts focusing on societal and economic impact and actively supporting and promoting science, technology, engineering and mathematics (STEM) education.
Safe Harbor Statement
Except for any historical information, the matters discussed in this press release contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements involve risks and uncertainties. A number of factors could cause actual results to differ from those indicated in the forward-looking statements, including the timing of completion of a trial, actual future clinical trial results being different than the results the company has obtained to date, and the company's ability to secure funding. Such statements are subject to a number of assumptions, risks and uncertainties. Readers are cautioned that such statements are not guarantees of future performance and those actual results or developments may differ materially from those set forth in the forward-looking statements. The company undertakes no obligation to publicly update or revise forward-looking statements, whether as a result of new information or otherwise.
For more information, please visit http://www.heponline.com.
Contact:
David Sasso
954-990-5451
Get more news on:SYMBOLS: HEPINEWS TYPE: SECTORS: Health Care, Life Sciences Tools and Services, Pharmaceuticals
Amigo Mike
Thanks for the digging. I agree it is harder to buy size on the bid but kind of nice see what's really on the offer.
I too, am looking forward to some info from HEPI. It is unfortunate that they have left their shareholders in the dark for so long that major damage has been done to the stock price. I have been a buyer on the way down including a little .135 yesterday. Hopefully in the future, the shareholders will have their payday.
Mike - Thank you for posting the new FINRA rules. That certainly does explain the large bids and offers. Last week, there was an offer for 1.9 million shares for sale on MNAP. Needless to say, I knew I couldn't "lift" him. LOL
Atleast we can "see" (better)what is available for sale on HEPI now
Industrial Nanotech Inc. Announces Expansion into Military Ship and Vehicle Applications
Last update: 4/7/2011 8:36:00 AM
NAPLES, Fla., Apr 07, 2011 (BUSINESS WIRE) -- Industrial Nanotech, Inc. (INTK), an emerging global leader in nanotechnology based energy saving solutions, today announced that the Company has completed testing and analysis of the use of Nansulate(R) for specific applications in military ships and vehicles. Nansulate(R) is the Company's patented product line of award winning specialty coatings containing a nanotechnology based material and which are well-documented to provide the combined performance qualities of thermal insulation, corrosion prevention, resistance to mold growth, fire resistance, chemical resistance and lead encapsulation in an environmentally safe, water-based, coating formulation.
"We began a series of testing procedures for the US Military several years ago and have recently been working with a consultant to define the most suitable applications for the Company's product line in this market," states Stuart Burchill, CEO/CTO of Industrial Nanotech, Inc. "Pipelines on nuclear powered submarines and ships and the interior walls of armored tanks and personnel carriers have been identified as areas in which Nansulate(R) coating technology can provide a unique value added benefit. We will be working with both current and former members of the military to implement the use of Nansulate in these areas."
Nansulate(R) has been utilized for a number of military applications which include: The U.S. Army Corps of Engineers in Vicksburg, MS for pipe insulation, the U.S. Navy at the Norfolk Naval Shipyard and Pearl Harbor Naval Base for lead encapsulation in buildings, at the Portsmouth Naval Shipyard for insulation and corrosion control of metal dock buildings, and by the Naval Business Center in Philadelphia for pipe insulation and corrosion control.
These innovative nanotechnology-based products are manufactured in the United States. For further information on Nansulate(R) Sustainable Coatings visit: .
About Nansulate(R)
Nansulate(R) is the Company's patented product line of award winning, specialty coatings containing a nanotechnology based material and which are well-documented to provide the combined performance qualities of thermal insulation, corrosion prevention, resistance to mold growth, fire resistance, chemical resistance and lead encapsulation in an environmentally safe, water-based, coating formulation. The Nansulate(R) Product Line includes industrial, residential, agricultural and solar thermal insulation coatings. Additional information about the Company and its products can be found at their websites, () and (). Blog: , Twitter: , Facebook: .
About Industrial Nanotech Inc.
Industrial Nanotech Inc. is a global nanoscience solutions and research leader and member of the U.S. Greenbuilding Council and an official ALLY organization with the U.S. Dept. of Energy "Save Energy Now" program. The Company develops and commercializes new and innovative applications for sustainable nanotechnology which are sold worldwide.
Safe Harbor Statement
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic and business conditions, and the ability to attract and retain skilled personnel. The Company is not obligated to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.
SOURCE: Industrial Nanotech, Inc.
For Industrial Nanotech, Inc. Investor Relations: Rob Karbowsky, 800-767-3998 investini@industrial-nanotech.com
Copyright Business Wire 2011
Industrial Nanotech Inc. Announces Steam Pipe Project at Large Food Processing Facility 04/04 08:00 AM
NAPLES, Fla.--(BUSINESS WIRE)-- Industrial Nanotech, Inc. (INTK:$0.0290,$0.0040,16.00%) , an emerging global leader in nanotechnology based energy saving solutions, today announced that application of the Company's patented Nansulate® energy saving protective coatings at one of the world’s largest food processing facilities is underway.
“Nansulate’s ability to reduce loss of heat energy from steam pipes and protect against corrosion, reduce surface temperatures for worker safety, and reduce condensation are valuable performance qualities for many food processing facilities,” states Francesca Crolley, VP of Business Development for Industrial Nanotech, Inc. (INTK:$0.0290,$0.0040,16.00%) “We have had a great deal of experience successfully solving these problems for food and beverage processing facilities around the world, including Holiday Snacks, Kraft Foods, and Grupo Modelo, makers of Corona beer. This relatively new project at one of the world’s largest facilities is a natural progression of that track record of success.”
Corrosion is the deterioration of essential properties in a metal, due to reactions with its surroundings. In the most common usage of the word, this means a loss of an electron of metal reacting with either water or oxygen. Corrosion Under Insulation (CUI) is a localized corrosion occurring at the interface of a metal surface and the insulation on that surface. This can be a particularly severe form of corrosion because of the difficulty in detection due to the corrosion occurring beneath insulation. Inspections for corrosion under insulation are generally not completed regularly enough to eliminate this problem due to the cost of insulation removal and replacement and cost of labor. CUI can account for as much as 40 to 60 percent of a company’s piping maintenance costs. A study completed in 2001 by a research team of corrosion specialists in the USA reported the direct cost of corrosion under insulation to be $276 billion per year, with that number potentially doubling when indirect costs are also considered.
Nansulate® coatings have exceeded the rigorous corrosion test standard, GM9540P Accelerated Corrosion Test. The GM9540P is an advanced cyclic method originally developed by General Motors and now the corrosion test preferred by the US Navy and many industries. GM9540P is useful because it replicates many of the worst-case environments. The popularity of cyclic testing comes from the improved reliability of results that can be correlated with actual use. Testing was done simultaneously on a steel control (uncoated) panel and panels coated with Nansulate®. The results show that after 1 cycle of the test, the steel control (uncoated) panel failed with 100% red rust present, and that after 24 cycles of the test, the Nansulate coated panel passed with no red rust present. Passing 8 cycles is considered the standard for an anticorrosion coating. The testing was performed by Assured Testing Services, an independent accredited laboratory specializing in corrosion testing.
According to the U.S. Department of Energy (DOE), over 45% of all the fuel burned by U.S. manufacturers is used to create steam. In a recent project specification the Company did for a large food manufacturing customer utilizing a DOE table for heat loss of uninsulated steam lines, energy savings achieved from insulating steam lines was estimated over 2,000 feet of 4” diameter pipe at 150 PSIG pressure. Annual energy savings from use of Nansulate® insulation and corrosion prevention coatings were estimated to be $84,130.88, with monthly savings being $7,010.90, and payback in less than six months. Calculators based on DOE steam heat loss tables can be downloaded at: www.nansulate.com/free_energy_saving_assessment.htm.
For further information on Nansulate® Sustainable Coatings visit: www.nansulate.com
About Nansulate®
Nansulate® is the Company's patented product line of award winning, specialty coatings containing a nanotechnology based material and which are well-documented to provide the combined performance qualities of thermal insulation, corrosion prevention, resistance to mold growth, fire resistance, chemical resistance and lead encapsulation in an environmentally safe, water-based, coating formulation. The Nansulate® Product Line includes industrial, residential, agricultural and solar thermal insulation coatings. Additional information about the Company and its products can be found at their websites, (www.industrial-nanotech.com) and (www.nansulate.com). Blog: www.nansulate.com/nanoblog, Twitter: www.twitter.com/NanoPioneer, Facebook: www.facebook.com/Nansulate.
About Industrial Nanotech Inc. (INTK:$0.0290,$0.0040,16.00%)
Industrial Nanotech Inc. (INTK:$0.0290,$0.0040,16.00%) is a global nanoscience solutions and research leader and member of the U.S. Greenbuilding Council and an official ALLY organization with the U.S. Dept. of Energy "Save Energy Now" program. The Company develops and commercializes new and innovative applications for sustainable nanotechnology which are sold worldwide.
Safe Harbor Statement
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic and business conditions, and the ability to attract and retain skilled personnel. The Company is not obligated to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.
Source: Industrial Nanotech, Inc. (INTK:$0.0290,$0.0040,16.00%)
Health Enhancement Products Updates Shareholders on Its Top Three Initiatives 03/21 08:30 AM
SCOTTSDALE, AZ -- (MARKET WIRE) -- 03/21/11 -- Health Enhancement Products, Inc. (HEPI:$0.23,00$0.00,000.00%) today outlined recent developments within the company in an effort to keep shareholders informed of its progress.
HEPI has been notified by its exclusive distributor, Xooma, that it has re-branded HEPI's ProAlgaZyme® product as "Kardiaxyme." (Xooma assumed Zus' rights and obligations under the distribution agreement between HEPI and Zus). Xooma plans to officially launch the newly branded product with its impressive new packaging within the next 45 days. Individuals who wish to purchase the product now can do so by contacting Xooma at www.kardiaxyme.com. Xooma has already completed a successful pre-launch of the Kardiaxyme product to a select group of distributors. Based on the results of this pre-launch, Xooma has requested that HEPI expand its production to a level that is more than twenty times HEPI's previous capacity. The company is hopeful that the expected increase in orders from Xooma will result in much improved operating cash flows.
HEPI recently announced the leasing of a new facility which it intends to use for its headquarters and production space. HEPI's objectives in seeking new space were threefold. First, the company needed a space that it could more easily convert into a GMP (good manufacturing practice) compliant facility. Secondly, the company was seeking a more efficient manufacturing space that could help it overcome production challenges. Thirdly, there was a desire to reduce operating expenses, if possible. The company believes that the new space meets all of the above objectives.
HEPI's Research and Development efforts have been directed toward actively pursuing an analysis of PAZ? to try and identify the "class of compounds," and the "active ingredient," to identify the single molecule or molecules, if possible, responsible for the potential cholesterol benefits the company's testing has identified. Substantial time, money, and effort have been expended in this regard. The company believes that it is making substantial progress towards achieving these hoped for results, but more investigation is needed. The company plans to update shareholders as the identification process is completed.
John Gorman, HEPI Executive Vice President of Operations, commented, "We are pleased that we now have a facility that with appropriate improvements can accommodate production of our product on a mass scale. Xooma will be an excellent marketing partner as they now have first-hand experience when discussing our product." Mr. Gorman concluded, "Moving into our new facility will allow us to more fully automate everything from growing, harvesting, filtering and bottling in a straight line production. It marks another important milestone in allowing us to finally begin the process of monetizing our valuable asset."
About Health Enhancement Products, Inc. (HEPI:$0.23,00$0.00,000.00%)
Health Enhancement Products, Inc. (HEPI:$0.23,00$0.00,000.00%) is a health & wellness company engaged in the development of products comprised of pure, all-natural compounds that can be used as a dietary supplement and food additive. The Company's product is ProAlgaZyme ® (PAZ?) a liquid product drawn from living algae grown in purified water. The water in which the algae are grown is drawn off, filtered and bottled under the trademark ProAlgaZyme ®.
Safe Harbor Statement
Except for any historical information, the matters discussed in this press release contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements involve risks and uncertainties. A number of factors could cause actual results to differ from those indicated in the forward-looking statements, including the timing of completion of the company's studies, actual future clinical trial results being different than the results the company has obtained to date, the company's ability to rapidly and substantially expand its production, the ability of the company to achieve GRAS status, and the company's ability to secure funding. Such statements are subject to a number of assumptions, risks and uncertainties. Readers are cautioned that such statements are not guarantees of future performance and those actual results or developments may differ materially from those set forth in the forward-looking statements. The company undertakes no obligation to publicly update or revise forward-looking statements, whether as a result of new information or otherwise.
For more information, please visit http://www.heponline.com.
Contact:
David Sasso
954-990-5451
Amigomike - This is traderking60 (lbergus). Thanks for all your insight and your moderation of this board. When this company has MLM, production or ID news, it will be nice to have a baord that is not plagued with mindless bashers.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report Pursuant
to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) February 28, 2011
Health Enhancement Products, Inc.
(Exact Name Of Registrant As Specified In Its Charter)
Nevada
(State or Other Jurisdiction of Incorporation)
87-0699977000-30415
(I.R.S. Employer Identification No.)(Commission File Number)
7740 East Evans Rd., Suite A100, Scottsdale, AZ 85260
(Address of Principal Executive Offices) (Zip Code)
(480) 385-3800
(Registrant’s Telephone Number, Including Area Code)
N/A
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
. Communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
. Material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
.Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
.Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01.Other Events
On February 28, 2011, the Registrant and BCO 83, LLC entered into a lease agreement covering approximately 10,000 square feet of office/warehouse space in Scottsdale, Arizona. The lease is for a term of three years and calls for monthly rent payments of approximately $5,400, plus insurance, taxes and maintenance (the lease is a “triple net” lease). The Registrant intends to relocate its corporate headquarters and bottling operations to this new facility as soon as the facility is ready for occupancy (estimated within thirty days).
The Registrant also recently terminated a month to month tenancy for a space it was using for secondary warehousing and bottling operations. This space comprised approximately 2,300 square feet and the monthly rent was approximately $3,300.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: March 7, 2011HEALTH ENHANCEMENT PRODUCTS, INC.
By /s/John Gorman
John Gorman, EVP - Operations